LexDanaLexDanabeta
Inventor

Gustave Bergnes

Inventor
Pacifica, CA, US

Overview

60→
Patents
2002–2020
Patent span
Chemistry
Primary field (CPC C)

Patents· 60 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds38%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
A61KPreparations for medical, dental or toiletry purposes12%
C07CAcyclic or carbocyclic compounds5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
Y02ATechnologies for adaptation to climate change4%
C07BGeneral methods of organic chemistry1%
C07KPeptides1%
PatentTitleYear
10,765,624Amino-pyrimidine skeletal muscle modulators202010,696,672Amino acid compounds and methods of use202010,604,520N-acyl amino acid compounds and methods of use202010,272,030Amino-pyrimidine skeletal muscle modulators201910,076,519Substituted pyridazines as skeletal muscle modulators20189,994,528Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use20189,730,886'Amino-pyrimidine skeletal muscle modulators'20179,604,965'Substituted pyridazines as skeletal muscle modulators'20179,278,962'Certain heterocycles, compositions thereof, and methods for their use'20169,133,123'Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use'20159,018,223'Certain amino-pyrimidines, compositions thereof, and methods for their use'20158,969,346'Amino-pyridazine skeletal muscle modulators'20158,962,632'Certain amino-pyrimidines, compositions thereof, and methods for their use'20158,772,507'Imidazole-benzamide anti-cancer agents'20148,759,380'Certain heterocycles, compositions thereof, and methods for their use'20148,686,007'Certain heterocycles, compositions thereof, and methods for their use'20148,633,236'Compounds, compositions and methods'20148,470,838'Methods and compositions utilizing quinazolinones'20138,329,928'Compounds, compositions and methods'20128,207,340'Imidazopyridinyl benzamide mitotic kinesin inhibitors'20128,163,919'Imidazopyridinyl benzamide mitotic kinesin inhibitors'20128,119,678'Compounds, compositions and methods'20128,008,311'Methods and compostions utilizing quinazolinones'20117,998,976'Certain chemical entities, compositions and methods'20117,989,469'Certain chemical entities, compositions, and methods'20117,919,524'Compounds, compositions and methods'20117,851,484'Certain chemical entities, compositions, and methods'20107,795,448'Imidazoyl-benzamide anti-cancer agents'20107,671,200'Quinazolinone KSP inhibitors'20107,629,477'Compounds, compositions and methods'20097,618,981'Imidazopyridinyl-benzamide anti-cancer agents'20097,589,098'Methods and compositions utilizing quinazolinones'20097,582,668'Imidazoyl-benzamide anti-cancer agents'20097,572,814'3,5-dibenzoyl-4-phenyl-piperidine anti-cancer compounds'20097,557,115'Compounds, compositions, and methods'20097,528,137'Compounds, compositions, and methods'20097,504,413'N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases'20097,491,746'Compounds, compositions and methods'20097,482,343'Compounds, methods and compositions'20097,476,743'Compounds, compositions, and methods'20097,439,254'Compounds, compositions, and methods'20087,294,634'Methods and compositions utilizing quinazolinones'20077,271,167'Compounds, compositions, and methods'20077,230,000'Methods and compositions utilizing quinazolinones'20077,214,800'Compounds, compositions, and methods'20077,211,580'Compounds, compositions, and methods'20077,208,487'Compounds, compositions and methods'20077,166,595'Compounds, methods and compositions'20077,161,002'Syntheses of quinazolinones'20077,105,668'Methods and compositions utilizing quinazolinones'20067,041,676'Compounds, compositions, and methods'20067,009,049'Syntheses of quinazolinones'20066,949,538'Compounds, compositions, and methods'20056,924,376'Compounds, compositions and methods'20056,831,085'Methods and compositions utilizing quinazolinones'20046,753,428'Process for the racemization of chiral quinazolinones'20046,630,479'Methods and compositions utilizing quinazolinones'20036,562,831'Methods and compositions utilizing quinazolinones'20036,545,004'Methods and compositions utilizing quinazolinones'20036,423,519'Compositions and methods for inhibiting fungal growth'2002

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2002Based in Belmont, MA, US· patent location history
2003–2020Patents assigned to CYTOKINETICS INC (50)· patent assignee history
2003–2020Based in Pacifica, CA, US· patent location history
2005–2009Patents assigned to SMITHKLINE BEECHAM CORP (15)· patent assignee history
2005–2014Based in Pacificia, CA, US· patent location history
2007–2014Based in South San Francisco, CA, US· patent location history
2012–2016Patents assigned to BERGNES GUSTAVE (14)· patent assignee history
2012–2016Patents assigned to QIAN XIANGPING (9)· patent assignee history
2012–2016Patents assigned to ASHCRAFT LUKE W (8)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
CYTOKINETICS INC502003–2020
SMITHKLINE BEECHAM CORP152005–2009
BERGNES GUSTAVEself142012–2016
QIAN XIANGPING92012–2016
ASHCRAFT LUKE W82012–2016
Locations
LocationPatentsSpan
Pacifica, California, US442003–2020
Pacificia, California, US82005–2014
South San Francisco, California, US72007–2014
Belmont, Massachusetts, US12002